Brief: Organovo Qtrly Loss Per Share $0.05

VivoSim Labs

08/11/2018 22:01

Nov 8 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO AFFIRMS KEY CLINICAL DEVELOPMENT GOALS; COMPANY
REPORTS
FISCAL SECOND-QUARTER 2019 RESULTS
    * Q2 REVENUE $900,000 VERSUS I/B/E/S VIEW $921,000
    * QTRLY LOSS PER SHARE $0.05
    * REMAIN ON TRACK FOR A PRE-IND MEETING WITH FDA FOR OUR
LEAD
INDICATION IN CALENDAR 2019

Source text for Eikon:  ID:nGNXc343yf 
Further company coverage:  ONVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))